companies innovating in obesity treatment glp-1 drugs 2025 Unpacking $100B+ Market Opportunity: What It Means for Biopharma, Payers, and Providers GLP-1 Drugs: 2025 Pulse Survey

Al-Mansouri A, Al-Ali FS, Hamad AI, Mohamed Ibrahim MI, Kheir N, Ibrahim RA, et al

Research has examined its potential to support tissue repair by accelerating skin, tendon, and ligament healing via angiogenesis and endothelial cell modulation

Studies showed that 91% of people who took tirzepatide (at 15 mg) lost at least 5% of their weight and 57% of people achieved at least a 20% weight reduction after 72 weeks

Studies indicate that a deficiency in vitamin K may also weaken bones, potentially increasing the risk of osteoporosis, and could encourage the calcification of arteries and other soft tissues (Marriott et al

Inhibitor experiments: If an inhibitor lowers a response, the blocked pathway may be involved